On Feb. 19, 2021, BioNTech announced the submission of new data to the FDA demonstrating the stability of…
On Feb. 19, 2021, Luminex announced that it had received $11.3 million in funding from the Biomedical Advanced…
On Feb. 18, 2021, Agilent Technologies announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay…
On Feb. 18, 2021, scientists at the University of Oxford announced that the Randomised Evaluation of COVID-19 Therapy…
On Feb. 18, 2021, Novavax and announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to…
On Feb. 18, 2021, Washington University pediatric infectious diseases doctors announced plans to launch clinical trials in the…
On Feb. 18, 2021, Pacific Biosciences announced that Labcorp had increased its commitment to highly accurate HiFi sequencing…
On Feb. 18, 2021, Pfizer and BioNTech announced that the first participants hadbeen dosed in a global Phase…
On Feb. 17, 2021, the NIH annunced funding of a study to evaluate the effects of remdesivir in…
On Feb. 17, 2021, Novartis announced that it had entered into a grant agreement with the Bill &…
On Feb. 17, 2021, TGen, an affiliate of City of Hope announced that it had found a way…
On Feb. 17, 2021, Moderna announced that the European Commission had purchased an additional 150 million doses of…
On Feb. 17, 2021, Altimmune announced that the U.S. Food and Drug Administration (FDA) had cleared the Companyls…
On Feb. 17, 2021, LabCorp announced the availability of a new laboratory-based antigen test that will help doctors…
On Feb. 17, 2021, BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million…
On Feb. 17, 2021, Immunic announced that its lead asset, IMU-838, the company’s selective oral DHODH inhibitor, had…
On Feb. 17, 2021, BioNTech announced results from an in vitro study that provided additional data on the…
On Feb. 16, 2021, Johnson & Johnson announced that subsidiary Janssen Biotech, has submitted a conditional Marketing Authorisation…
On Feb. 16, 2021, in a study led by National Institutes of Health (NIH) researchers, scientists found that…
On Feb. 16, 2021, Anixa Biosciences announced that animal testing had commenced with two proprietary compounds that have…
On Feb. 16, 2021, XPhyto and 3a-diagnostics announced that all actions and procedures required for its European regulatory…
On Feb. 16, 2021, AIM ImmunoTech announced that it had received approval from the required Ethics Committee in…
On Feb. 16, 2021, Moderna provided a supply update for their COVID-19 Vaccine in the United States, reporting…
On Feb. 16, 2021, Meridian Bioscience provided an update on its application for Emergency Use Authorization (EUA) with…
On Feb. 16, 2021, Lonza, formerly Bend Research, announced that it was expanding and refining first-in-human services at…
On Feb. 15, 2021, Novavax and SK Bioscience announced an expanded collaboration and license agreement. In addition to…
On Feb. 15, 2021, the WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving…
On Feb. 14, 2021, the WHO announced that Health authorities in Guinea had declared an outbreak of Ebola…
On Feb. 13, 2021, the University of Oxford, together with three partner sites in London, Southampton and Bristol,…
On Feb. 12, 2021, BioNTech announced that the U.S. government had exercised its option for an additional 100…